Literature DB >> 19041054

Unrelated donor hematopoietic cell transplantation: factors associated with a better HLA match.

Jason Dehn1, Mukta Arora, Stephen Spellman, Michelle Setterholm, Mary Horowitz, Dennis Confer, Daniel Weisdorf.   

Abstract

The impact of non-HLA patient factors on the match of the selected unrelated donor (URD) for hematopoietic cell transplantation (HCT) has not been fully evaluated. National Marrow Donor Program (NMDP) data for 7486 transplants using peripheral blood stem cells (PBSCs) or bone marrow from years 2000 to 2005 were evaluated using multivariate logistic regression to identify independent non-HLA patient factors associated with completing a more closely matched URD transplant. Advanced (intermediate- and late-stage) disease was significantly associated with an increased likelihood of transplant using a less-matched (partially matched or mismatched) donor. Additionally, Black patients were 2.83 times, Asian patients 2.05 times, and Hispanic patients 1.73 times more likely to have a less-matched HCT donor than Caucasian patients. Younger patients, HCT at lower volume centers, and in earlier years had significantly higher likelihood of having a less HLA matched URD transplant. Our analysis provides encouraging evidence of HLA matching improvement in recent years. Initiating a patient's URD search early in the disease process, especially for patients from non-Caucasian racial and ethnic groups, will provide the best likelihood for identifying the best available donor and making informed transplant decisions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041054      PMCID: PMC3319684          DOI: 10.1016/j.bbmt.2008.09.009

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  12 in total

1.  A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs.

Authors:  Carolyn Katovich Hurley; Marcelo Fernandez-Vina; William H Hildebrand; Harriet J Noreen; Elizabeth Trachtenberg; Thomas M Williams; Lee Ann Baxter-Lowe; Ann B Begovich; Effie Petersdorf; Annamalai Selvakumar; Peter Stastny; Janet Hegland; Robert J Hartzman; Michael Carston; Sharavi Gandham; Craig Kollman; Gene Nelson; Stephen Spellman; Michelle Setterholm
Journal:  Hum Immunol       Date:  2006-10-25       Impact factor: 2.850

Review 2.  National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants.

Authors:  Robert A Bray; Carolyn K Hurley; Naynesh R Kamani; Ann Woolfrey; Carlheinz Müller; Stephen Spellman; Michelle Setterholm; Dennis L Confer
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742

3.  Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.

Authors:  E W Petersdorf; J A Hansen; P J Martin; A Woolfrey; M Malkki; T Gooley; B Storer; E Mickelson; A Smith; C Anasetti
Journal:  N Engl J Med       Date:  2001-12-20       Impact factor: 91.245

4.  Ordinal regression models for epidemiologic data.

Authors:  B G Armstrong; M Sloan
Journal:  Am J Epidemiol       Date:  1989-01       Impact factor: 4.897

5.  The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.

Authors:  Yasuo Morishima; Takehiko Sasazuki; Hidetoshi Inoko; Takeo Juji; Tatsuya Akaza; Ken Yamamoto; Yoshihide Ishikawa; Shunichi Kato; Hiroshi Sao; Hisashi Sakamaki; Keisei Kawa; Nobuyuki Hamajima; Shigetaka Asano; Yoshihisa Kodera
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

6.  HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants.

Authors:  Bronwen E Shaw; Steven G E Marsh; Neema P Mayor; Nigel H Russell; J Alejandro Madrigal
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

7.  Limits of HLA mismatching in unrelated hematopoietic cell transplantation.

Authors:  Effie W Petersdorf; Claudio Anasetti; Paul J Martin; Ted Gooley; Jerald Radich; Mari Malkki; Ann Woolfrey; Anajane Smith; Eric Mickelson; John A Hansen
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113

8.  Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

Authors:  Neal Flomenberg; Lee Ann Baxter-Lowe; Dennis Confer; Marcelo Fernandez-Vina; Alexandra Filipovich; Mary Horowitz; Carolyn Hurley; Craig Kollman; Claudio Anasetti; Harriet Noreen; Ann Begovich; William Hildebrand; Effie Petersdorf; Barbara Schmeckpeper; Michelle Setterholm; Elizabeth Trachtenberg; Thomas Williams; Edmond Yunis; Daniel Weisdorf
Journal:  Blood       Date:  2004-06-10       Impact factor: 22.113

9.  Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient.

Authors:  E W Petersdorf; T A Gooley; C Anasetti; P J Martin; A G Smith; E M Mickelson; A E Woolfrey; J A Hansen
Journal:  Blood       Date:  1998-11-15       Impact factor: 22.113

10.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

View more
  18 in total

Review 1.  Progress in haploidentical stem cell transplantation.

Authors:  Ulas D Bayraktar; Richard E Champlin; Stefan O Ciurea
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-09       Impact factor: 5.742

2.  Modeling coverage gaps in haplotype frequencies via Bayesian inference to improve stem cell donor selection.

Authors:  Yoram Louzoun; Idan Alter; Loren Gragert; Mark Albrecht; Martin Maiers
Journal:  Immunogenetics       Date:  2017-11-09       Impact factor: 2.846

3.  Extensive haplotype diversity in African American mothers and their cord blood units.

Authors:  B Tu; N Leahy; R Yang; N Cha; K Kariyawasam; L Hou; Y Xiao; C Masaberg; D Pulse-Earle; M Maiers; J Ng; J Kurtzberg; C K Hurley
Journal:  Tissue Antigens       Date:  2012-11-20

4.  Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whites.

Authors:  B K Hamilton; L Rybicki; M Sekeres; M Kalaycio; R Hanna; R Sobecks; R Dean; H Duong; B T Hill; B Bolwell; E Copelan
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

Review 5.  How I treat: the selection and acquisition of unrelated cord blood grafts.

Authors:  Juliet N Barker; Courtney Byam; Andromachi Scaradavou
Journal:  Blood       Date:  2010-12-13       Impact factor: 22.113

6.  GPI-80 defines self-renewal ability in hematopoietic stem cells during human development.

Authors:  Sacha Leandra Prashad; Vincenzo Calvanese; Catherine Yao Yao; Joshua Kaiser; Yanling Wang; Rajkumar Sasidharan; Gay Crooks; Mattias Magnusson; Hanna Katri Annikki Mikkola
Journal:  Cell Stem Cell       Date:  2014-11-13       Impact factor: 24.633

7.  Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.

Authors:  Juliet N Barker; Courtney E Byam; Nancy A Kernan; Sinda S Lee; Rebecca M Hawke; Kathleen A Doshi; Deborah S Wells; Glenn Heller; Esperanza B Papadopoulos; Andromachi Scaradavou; James W Young; Marcel R M van den Brink
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-25       Impact factor: 5.742

8.  Race and ethnicity in decisions about unrelated hematopoietic stem cell donation.

Authors:  Galen E Switzer; Jessica G Bruce; Larissa Myaskovsky; Andrea DiMartini; Diana Shellmer; Dennis L Confer; Linda K Abress; Roberta J King; Allyson G Harnaha; Sibylle Ohngemach; Mary Amanda Dew
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

9.  The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.

Authors:  Suzanna M van Walraven; Anneke Brand; Jack N A Bakker; Martin B A Heemskerk; Suzan Nillesen; Marc B Bierings; Laura B Bungener; Bouke G Hepkema; Arjan Lankester; Arnold van der Meer; Kees Sintnicolaas; Judith A E Somers; Eric Spierings; Marcel G J Tilanus; Christien E M Voorter; Jan J Cornelissen; Machteld Oudshoorn
Journal:  Haematologica       Date:  2016-08-25       Impact factor: 9.941

10.  Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment.

Authors:  Johnnie J Orozco; Aimee Kenoyer; Ethan R Balkin; Ted A Gooley; Donald K Hamlin; D Scott Wilbur; Mark D Hylarides; Sofia H L Frost; Raya Mawad; Paul O'Donnell; Brenda M Sandmaier; Ephraim J Fuchs; Leo Luznik; Damian J Green; Ajay K Gopal; Oliver W Press; John M Pagel
Journal:  Blood       Date:  2015-11-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.